Medicare ACO Plan Could Improve Rx Compliance But Lacks Guidance On Drug Management Policies
Executive Summary
Medicare-sanctioned accountable care organizations could significantly improve drug adherence among beneficiaries as a way to prevent more costly medical interventions later, under a widely-anticipated CMS proposal.
You may also be interested in...
Medicare ACO Cost Incentives For Part B-To-D Rx Shifts Worry Stakeholders
CMS should look for ways to ensure that financial incentives for Medicare accountable care organizations do not promote inappropriate shifts in prescribing from the Part B benefit to Part D, biotech and clinician groups urge in comments filed with the agency June 6.
Medicare ACO Cost Incentives For Part B-To-D Rx Shifts Worry Stakeholders
CMS should look for ways to ensure that financial incentives for Medicare accountable care organizations do not promote inappropriate shifts in prescribing from the Part B benefit to Part D, biotech and clinician groups urge in comments filed with the agency June 6.
Booz VP Advises Pharma: Show Value To Gain Market Access
Pharma's rapidly changing commercial environment has forced companies to re-think their traditional approaches to marketing.